Relapsed Adult AML: Clinical Trials

1 trial for Relapsed Adult AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Relapsed Adult AML: new trials by email Literature Review of Relapsed Adult AML trials Research Report on Relapsed Adult AML

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine,Cytarabine, G-CSF for Refractory or Relapsed AML
Visilizumab - Immunotherapy, Refractory Leukemia
Phase 3UnknownThe First Affiliated Hospital of Soochow University302021-05-012021-12-03

Narrower conditions

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Azacitidine (1)  ·  Cytarabine (1)  ·  Homoharringtonine (1)  ·  visilizumab (1)

Sponsors

The First Affiliated Hospital of Soochow University (1)

Countries

China (1)

Top investigators

Han Yue, Ph.D (1)